Literature DB >> 3526949

Dietary factors and alcoholic cirrhosis.

A A Nanji, S W French.   

Abstract

Mortality from cirrhosis in many countries deviates markedly from that expected for a given per capita alcohol intake. We investigated the possibility that dietary factors might explain the deviation expected and actual mortality rates in different countries. Deviations from expected cirrhosis mortality was calculated as a percentage for 17 different countries, all of whom had carrier rates for hepatitis B virus of less than 2%. The percentage of deviation was correlated with dietary intake of saturated fat, polyunsaturated fat, cholesterol, and also with mortality from ischemic heart disease. The percentage of deviation correlated inversely with dietary cholesterol (r = -0.86, p 0.001) and saturated fat (r = -0.80, p 0.001) and positively with polyunsaturated fats (r = -0.55 p 0.05). This suggests that both saturated fat and cholesterol protect against alcoholic cirrhosis while polyunsaturated fats promote cirrhosis. The correlation between percentage of deviation and ischemic heart disease (r = -0.78, p 0.002) suggests that those factors that promote ischemic heart disease protect against alcoholic cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3526949     DOI: 10.1111/j.1530-0277.1986.tb05088.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  22 in total

1.  CCl4-induced hepatic injury in mice fed a Western diet is associated with blunted healing.

Authors:  Monique Allman; Latausha Gaskin; Chantal A Rivera
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

2.  Dietary saturated fatty acids reduce hepatic lipid accumulation but induce fibrotic change in alcohol-fed rats.

Authors:  Ya-Ling Chen; Hsiang-Chi Peng; Xiang-Dong Wang; Suh-Ching Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

Review 3.  Chemical dependency in women. Meeting the challenges of accurate diagnosis and effective treatment.

Authors:  K B Unger
Journal:  West J Med       Date:  1988-12

4.  Role of transforming growth factor-[beta]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease.

Authors:  A A Nanji; S R Tahan; M Golding; S Khwaja; A Rahemtulla; E N Lalani
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

Review 5.  Rodent models of alcoholic liver disease.

Authors:  R Goldin
Journal:  Int J Exp Pathol       Date:  1994-02       Impact factor: 1.925

6.  Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease.

Authors:  Irina A Kirpich; Joseph Petrosino; Nadim Ajami; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Shirish S Barve; Xinmin Yin; Xiaoli Wei; Xiang Zhang; Craig J McClain
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

7.  Eicosanoid production in experimental alcoholic liver disease is related to vitamin E levels and lipid peroxidation.

Authors:  A A Nanji; S Khwaja; S M Sadrzadeh
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

8.  Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol.

Authors:  Irina A Kirpich; Wenke Feng; Yuhua Wang; Yanlong Liu; Juliane I Beier; Gavin E Arteel; K Cameron Falkner; Shirish S Barve; Craig J McClain
Journal:  Alcohol       Date:  2013-02-26       Impact factor: 2.405

9.  Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera; LaTausha Gaskin; Monique Allman; Jia Pang; Kristen Brady; Patrick Adegboyega; Kevin Pruitt
Journal:  BMC Gastroenterol       Date:  2010-05-28       Impact factor: 3.067

10.  Relationship between dietary beef, fat, and pork and alcoholic cirrhosis.

Authors:  Francis Stephen Bridges
Journal:  Int J Environ Res Public Health       Date:  2009-09-10       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.